Revisiting Timing and Decision Modeling for Allogeneic Hematopoietic Stem-Cell Transplantation in Myelodysplastic

Corey Cutler1

  • 1Division of Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.